NG2-73 selectiely modulates receptors of the gamma-aminobutyric acid (GABA) neurotransmitter system and is one of seeral un partnered compounds in Neurogen's portfolio.
Commodities have until now primarily featured as a diversifier in investors' portfolios due to a tendency to rise in times of poor equity and bond market returns.